Vaccine Development Studies
Discover our research on vaccine development
Single-cell Profiling of Biostabilized Natural Human Skin Identifies Mast Cells as an Important Target of Injected mRNA-1273 COVID-19 Vaccine (EMBRN24)
Manon Scholaert1,2, Mathias Peries1, Emilie Braun1, Jeremy Martin2, Nadine Serhan2, Katarzyna Polak1, Alexia Loste2, Audrey Bruner2, Lilian Basso2, Benoit Chaput4, Eric Merle3, Pascal Descargues3, Emeline Pagès1, Nicolas Gaudenzio1,2 – 1Genoskin SAS, Toulouse, France – 2Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 – CNRS UMR5051 – University Toulouse III, France – 3Genoskin Inc, Salem MA, USA – 4Department of Plastic, Reconstructive and Aesthetic Surgery, Rangueil Hospital, CHU Toulouse, Toulouse, France.
Evaluation of Vaccine Potency with High-Dimensional Immune Profiling Using an Innovative Bio-stabilized Human Skin Model (WVC-DC24)
Manon Scholaert1,2, Mathias Peries1, Emilie Braun1, Jeremy Martin2, Nadine Serhan2, Alexia Loste2, Audrey Bruner2, Lilian Basso2, Anna Trevisiol1, Eric Merle3, Emeline Pagès1, Nicolas Gaudenzio1,2 – 1Genoskin SAS, Toulouse, France – 2Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 – CNRS UMR5051 – University Toulouse III, France – 3Genoskin Inc, Salem MA, USA
High-dimensional Profiling of Immune Response to Vaccines Using Biostabilized and Injectable Natural Human Skin (WVC-EU23)
Manon Scholaert1,2, Mathias Peries1, Emilie Braun1, Jeremy Martin2, Nadine Serhan2, Alexia Loste2, Audrey Bruner2, Lilian Basso2, Eric Merle3, Michael Pastore1, Pascal Descargues3, Emeline Pagès1, Nicolas Gaudenzio1,2 – 1Genoskin SAS, Toulouse, France – 2Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 – CNRS UMR5051 – University Toulouse III, France – 3Genoskin Inc, Salem MA, USA